
Notice of 2024 Interim Results
The Company's interim report and results press release will be available on the Company's website at
ENDS
About
Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in
For further information please contact:
Malin
Tel: +353 (0)1 901 5700
Davy Corporate Finance (Euronext Growth Listing Sponsor & Broker)
Tel: +353 1 679 6363
Sodali & Co (Media enquiries)
Tel: +353 87 236 5973
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the